Moleculin posts new investor presentation on website

Moleculin Biotech, Inc.

Filed under Item 7.01 as Regulation FD disclosure with Exhibit 99.1.
Presentation is dated February 2026; actual content is an image exhibit not parsed.
No specific financial, clinical, or operational data disclosed in the 8-K text.
Investors should review the presentation on the company's website for details.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.